Markku Jalkanen

}} Markku Jalkanen (born 1954) is a scientist, biotech entrepreneur and businessman from Turku, Finland. He is the CEO of Faron Pharmaceuticals, a Finnish biopharmaceutical company listed on London's Alternative Investment Market and Nasdaq's First North Growth Market. Jalkanen was the founding CEO and President of Biotie Therapies, the first publicly traded biotech-company in Finland. He is an advisor for the Finnish life-science fund, Inveni Capital. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Markku Jalkanen', query time: 0.02s Refine Results
  1. 1
    Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search